Deep Track Capital, LP 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 08:52 am Sale | 2025-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital, LP | 3,150,000 2.970% | -4,345,000 (-57.97%) | Filing |
| 2025-08-14 08:51 am Purchase | 2025-06-30 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital, LP | 7,495,000 8.580% | 1,918,442 (+34.40%) | Filing |
| 2025-05-15 08:47 am Sale | 2025-03-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital, LP | 5,576,558 6.390% | -523,442 (-8.58%) | Filing |
| 2024-02-14 08:57 am Purchase | 2023-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital, LP | 6,100,000 9.870% | 2,540,000 (+71.35%) | Filing |
| 2023-07-28 4:25 pm Purchase | 2023-07-20 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital, LP | 3,560,000 6.280% | 3,560,000 (New Position) | Filing |